MENU
PROK
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
ProKidney (PROK) Ownership - Who owns ProKidney?
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment... Show more
Profile
Industry
N/A
Address
2000 Frontis Plaza Boulevard
Phone
+1 336 999-7028
Employees
163
Web
https://www.prokidney.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
126.63M
P/E Ratio
N/A
Total Cash
358.29M
Projected Growth
N/A
Total Debt
3.24M
Revenue
76K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
2.77
Total Debt/Equity
N/A
Revenue/Share
0.00 USD as % of share price
Fundamentals
PROK
Capitalization
127M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
358M
Total Cash/Share
2.77
Total Debt
3.24M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.00%
Revenue
76K
ROE
N/A
Book Value
-994.95M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.62
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
29K
Current Ratio
10.93
Current Revenue Per Employee
372.55
Dividends Per Share - Security
N/A
EBITDA
-158.49M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-14.20
Shares Held By Institutions
180M
Shares Outstanding - Current
130M
Total Liabilities
39.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
-58.237
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2000 Frontis Plaza Boulevard
Phone
+1 336 999-7028
Employees
163
Web
https://www.prokidney.com